Released Mar 1, 2017, after the close
10-K filed Mar 2, 2017, 61 days after period end · 0001144204-17-012234
Q4 2016 · 10-K
Revenue—
Net Income-$11.55M-$11.55M N/M vs Q4 2015N/M vs Q3 2016
EPS Diluted-$0.67-$0.67 N/M vs Q4 2015N/M vs Q3 2016
Operating Incomederived-$11,867,793N/M
Operating Cash Flowderived-$11,039,580N/M
Free Cash Flowderived-$11,151,486N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2016 | Q4 2015 | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$11.55M | -$7.75M | -$6.23M | -$6.05M |
| EPS Diluted | -$0.67 | -$0.45 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR